Tegretol Tablet, Extended Release
Product Images NDC 0078-0510

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tegretol (NDC 0078-0510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tegretol, Carbamazepine Structural Formula (Tegretol 02)

Chemical structure of carbamazepine, the active ingredient in Tegretol. The diagram shows the molecular arrangement with a three-ring system including two benzene rings and a central nitrogen-containing ring with an amide (CONH2) group attached.*

FDA Label Image

Principal Display Panel Ndc 0078-0509-05 Rx Only Tegretol® 200 mg Carbamazepine Usp 100 Tablets Pharmacist: Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tegretol 04)

The label for Tegretol 200 mg tablets, containing carbamazepine USP, from Novartis Pharmaceuticals Corporation. It indicates a package count of 100 tablets and includes the note for pharmacists to dispense with a Medication Guide separately. The label shows the National Drug Code (NDC) 0078-0509-05 and a prescription-only designation.*

FDA Label Image

Principal Display Panel Ndc 0078-0510-05 Rx Only Tegretol®-xr 100 mg (carbamazepine Extended-release Tablets) Tegretol-xr Tablets Must Be Swallowed Whole And Never Crushed Or Chewed. 100 Tablets Pharmacist: Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tegretol 05)

Label of Tegretol XR 100 mg extended-release tablets by Novartis Pharmaceuticals Corporation. The label indicates the medication is carbamazepine in tablet form with 100 tablets per package. Instructions specify the tablets must be swallowed whole and never crushed or chewed. The label includes NDC 0078-0510-05 and dispensing guidance for pharmacists.*

FDA Label Image

Principal Display Panel Ndc 0078-0511-05 Rx Only Tegretol®-xr 200 mg (carbamazepine Extended-release Tablets) Tegretol-xr Tablets Must Be Swallowed Whole And Never Crushed Or Chewed. 100 Tablets Pharmacist: Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tegretol 01)

Tegretol XR 200 mg extended-release tablets packaging label showing the product name, active ingredient carbamazepine, and strength. The label indicates the tablets must be swallowed whole without crushing or chewing. It includes a barcode, quantity of 100 tablets, pharmacist dispensing instructions, and manufacturer Novartis Pharmaceuticals Corporation.*

FDA Label Image

Principal Display Panel Ndc 0078-0512-05 Rx Only Tegretol®-xr 400 mg (carbamazepine Extended-release Tablets) Tegretol-xr Tablets Must Be Swallowed Whole And Never Crushed Or Chewed. 100 Tablets Pharmacist: Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tegretol 03)

Label for Tegretol XR 400 mg extended-release tablets, containing carbamazepine, in an oral tablet form. The package contains 100 tablets and is labeled for prescription use only. The product is manufactured by Novartis Pharmaceuticals Corporation. The label includes instructions to swallow tablets whole and not to crush or chew them, along with storage and dispensing information.*

FDA Label Image

Principal Display Panel Ndc 0078-0508-83 Tegretol® (carbamazepine Usp)suspension 100 mg/5 mL Important: Shake Well Before Using. Each 5 mL Contains 100 mg Carbamazepine Usp. 450 mL Dispense In Tight, Light-resistant Container (usp). Pharmacist: Dispense With Medication Guide Attached Or Provided Separately. Rx Only Novartis (Tegretol 06)

Tegretol Suspension 100 mg/5 mL oral liquid in a 450 mL bottle, containing carbamazepine USP. Label warns to shake well before use and states each 5 mL contains 100 mg carbamazepine USP. Packaged in a light-resistant container. Distributed by Novartis Pharmaceuticals Corporation and manufactured by Patheon Whitby Inc., Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.